✦ LIBER ✦

Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma

✍ Scribed by Stefan von Delius; Christian Lersch; Ewert Schulte-Frohlinde; Martina Mayr; Roland M Schmid; Florian Eckel

Book ID: 115010717
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 243 KB
Volume: 5
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-5-61

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of gemcitabine combined w

Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

✍ Jeeyun Lee; Tae-You Kim; Myung Ah Lee; Myung Ju Ahn; Hoon-Kyo Kim; Ho Yeong Lim; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 246 KB

Gemcitabine, 5-fluorouracil, and leucovo

Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma : A North Central Cancer Treatment Group Phase II Trial

✍ Steven R. Alberts; Hani Al-Khatib; Michelle R. Mahoney; Lawerence Burgart; Peter 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Phase II study of single-agent gemcitabi

Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer

✍ Takuji Okusaka; Hiroshi Ishii; Akihiro Funakoshi; Kenji Yamao; Shinichi Ohkawa; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 214 KB

A phase II trial of gemcitabine in patie

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili

A phase II trial of bryostatin-1 adminis

A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma

✍ Clamp, A R; Blackhall, F H; Vasey, P; Soukop, M; Coleman, R; Halbert, G; Robson, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 72 KB

Phase I/II trial of paclitaxel by 1-hour

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ John D. Hainsworth; Howard A. Burris III; Joan B. Erland; Lisa H. Morrissey; Ant 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

## BACKGROUND. The combination of paclitaxel and carboplatin is widely used in the treatment of patients with advanced nonsmall cell lung carcinoma. In this Phase I/II study the authors evaluated the feasibility, toxicity, and efficacy of adding a third active antineoplastic agent, gemcitabine, to